华鲁网群
综合内网 English
投资者关系
信息透明,信任同行
投资者关系
05
2025-06
Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Soft Capsules Having Obtained Drug Registration Certificate
05
2025-06
海外監管公告-關於取得二十碳五烯酸乙酯軟膠囊藥品註冊證書的公告
05
2025-06
Overseas Regulatory Announcement-Announcement on Isavuconazonium Sulfate for Injection Having Obtained Drug Registration Certificate
05
2025-06
海外監管公告-關於取得注射用硫酸艾沙康唑藥品註冊證書的公告
03
2025-06
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 May 2025
03
2025-06
截至二零二五年五月三十一日止月份之股份發行人的證券變動月報表
22
2025-05
Overseas Regulatory Announcement-Announcement on Ibuprofen Suspension Drops Having Obtained Drug Registration Certificate
22
2025-05
海外監管公告-關於取得布洛芬混懸滴劑藥品註冊證書的公告
19
2025-05
Overseas Regulatory Announcement-Announcement on Icosapent Ethyl Having Obtained the Notification of Approval of Marketing Application for Chemical Substance Drugs
19
2025-05
海外監管公告-關於二十碳五烯酸乙酯獲得化學原料藥上市申請批准通知書的公告
总条数: 59